Trials / Completed
CompletedNCT01604044
Highly Purified Menotropin (HP-hMG) Versus Recombinant FSH (rFSH) Plus Recombinant LH (rLH) in Intrauterine Insemination Cycles in Women ≥35 Years: a Prospective Randomized Trial.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 579 (actual)
- Sponsor
- Catholic University of the Sacred Heart · Academic / Other
- Sex
- Female
- Age
- 35 Years – 41 Years
- Healthy volunteers
- Accepted
Summary
This study evaluates the effects of different therapies in ovulation induction in Intrauterine Insemination Cycles.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Meropur 150 a day | one subcutaneous injection a day |
| DRUG | Gonal-f 150 plus Luveris 150 | one subcutaneous injection a day |
Timeline
- Start date
- 2012-05-01
- Primary completion
- 2013-09-01
- Completion
- 2013-09-01
- First posted
- 2012-05-23
- Last updated
- 2014-09-05
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01604044. Inclusion in this directory is not an endorsement.